VivoSeq
Ophthalmology

Persistent Corneal Epithelial Defect

0

Pipeline Programs↗

0

Active Trials↗

3

Companies Involved↗

Persistent Corneal Epithelial Defect is an early-stage landscape with 0 programs across 3 companies. The most active players are Noveome Biotherapeutics, formerly Stemnion, Kiora Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd..

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

60/100

Attrition Rate

40/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

N

Noveome Biotherapeutics, formerly Stemnion

0 programs

PreclinicalK

Kiora Pharmaceuticals, Inc.

0 programs

PreclinicalS

Santen Pharmaceutical Co., Ltd.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

5

clinical trials

Completed3 · 60%
Terminated2 · 40%

Clinical Trials

Trial Activity

ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects
Terminated·NNoveome Biotherapeutics, formerly Stemnion·Phase 2·NCT05066698·8 enrolled
A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defects
Completed·KKiora Pharmaceuticals, Inc.·Phase 2·NCT05436288·10 enrolled
Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects
Terminated·UUniversity of California, San Francisco·Phase 2·NCT01165450·2 enrolled
ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects
Completed·NNoveome Biotherapeutics, formerly Stemnion·Phase 2·NCT03687632·13 enrolled
Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial Defect
Completed·SSanten Pharmaceutical Co., Ltd.·Phase 2·NCT00988494·45 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)